New Study Shows Over Half of FDA Approved Drugs Were Never Comparison Tested


The cat is out of the Food & Drug Administration’s bag: the media is reporting that only around 50% of drugs approved as safe for Americans to take were ever submitted to comparative effectiveness testing at the time of their approval by the FDA, and approximately 75% of these new drugs had this information available where alternative treatment options existed.

Comparative effective data, the article explains, compares the new drug against other treatments to determine which is best. Which is safer? Which works best? In other words, is the Big Pharma drug the best one for the particular problem that the person is experiencing?

If it sounds like profits would be impacted by this, you're right.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Kenneth J. Allen & Associates | Attorney Advertising

Written by:


Kenneth J. Allen & Associates on:

JD Supra Readers' Choice 2016 Awards
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.